Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice

Feng Li1, Noel Y Calingasan, Fangmin Yu

  • 1Department of Neurology and Neuroscience, Weill Medical College of Cornell University, 525 East 68th Street, New York, NY 10021, USA.

Insights

Oxidative stress exacerbates Alzheimer's disease (AD) pathology. This study shows that reduced antioxidant enzyme manganese superoxide dismutase (MnSOD) significantly increases beta-amyloid (Abeta) in the brain, supporting antioxidant therapies for AD.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Oxidative stress is linked to beta-amyloid (Abeta) accumulation in Alzheimer's disease (AD) pathogenesis.
  • A direct in vivo causal link between oxidative stress and Abeta pathology remains unestablished.

Purpose of the Study:

  • To investigate the in vivo causal relationship between oxidative stress and Abeta pathology in Alzheimer's disease.
  • To determine if reduced antioxidant capacity promotes Abeta accumulation and plaque burden.

Main Methods:

  • Crossed mice with a knockout of one allele of manganese superoxide dismutase (MnSOD) with Tg19959 mice overexpressing mutated human beta-amyloid precursor protein (APP).
  • Assessed the impact of partial MnSOD deficiency (elevated oxidative stress) on brain Abeta levels and plaque burden.

Main Results:

  • Partial MnSOD deficiency significantly increased brain Abeta levels in Tg19959 mice.
  • Elevated oxidative stress led to a greater Abeta plaque burden in the AD mouse model.

Conclusions:

  • Oxidative stress directly promotes Alzheimer's disease pathogenesis.
  • Antioxidant strategies show promise for therapeutic intervention in AD.

Related Concept Videos